In Nature
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?
From my article in the December 18, 2019, issue of Nature (“Innovations In” section)
….Because finding new, successful drugs has become so much harder, the average cost of bringing one to market nearly doubled between 2003 and 2013 to $2.6 billion, according to the Tufts Center for the Study of Drug Development. These same challenges have increased the lab-to-market time line to 12 years, with 90 percent of drugs washing out in one of the phases of human trials. It’s no wonder, then, that the industry is enthusiastic about artificial-intelligence tools for drug development….Read more
David H. Freedman 